[PCRX] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
04-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 233.13%
YoY- -34.15%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 167,117 160,341 157,991 119,027 105,684 91,313 74,607 14.37%
PBT 13,640 -26,474 7,294 12,724 8,557 -2,518 -10,645 -
Tax 4,661 -6,938 466 2,355 398 253 35 125.81%
NP 8,979 -19,536 6,828 10,369 8,159 -2,771 -10,680 -
Tax Rate -34.17% - -6.39% -18.51% -4.65% - - -
Total Cost 158,138 179,877 151,163 108,658 97,525 94,084 85,287 10.82%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 5.37 -12.18 4.32 8.71 7.72 -3.03 -14.32 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS 0.19 -0.43 0.15 0.24 0.19 -0.07 -0.26 -
EPS Diluted 0.19 -0.43 0.15 0.23 0.19 -0.07 -0.26 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.